CMS Drafts Rules to Slash Medicare Drug Prices Soon
Published Date: 5/15/2025
Notice
Summary
CMS is inviting everyone to share their thoughts on new rules for negotiating drug prices under Medicare starting in 2026. This affects drug makers and Medicare patients by aiming to lower medicine costs through fair price limits. The changes kick in over the next few years, helping save money and making medicines more affordable.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Medicare drug prices capped 2026–2028
You (Medicare patients) are affected by new Medicare Drug Price Negotiation Program rules that set a "maximum fair price" for certain medicines for 2026, 2027, and 2028. CMS says the changes aim to lower medicine costs and make medicines more affordable, and CMS is seeking public comment on draft guidance for those years.
Manufacturers must effectuate fair prices
If you are a drug manufacturer, CMS' draft guidance covers manufacturer effectuation of the "maximum fair price" and negotiation cycles for drugs for 2026, 2027, and 2028. The guidance applies to drug makers as CMS implements the Inflation Reduction Act negotiation and renegotiation process for those years.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-12069, Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
2026-10890, Medicare Program; Alternative Payment Model Updates and the Increasing Organ Transplant Access (IOTA) Model
Starting July 1, 2026, Medicare is updating the Increasing Organ Transplant Access (IOTA) Model to help kidney transplant hospitals do even better at getting more people transplanted and improving care quality. These changes affect hospitals involved in kidney transplants and aim to make the process smoother and more effective, with new payment rules that reward success. This update is part of a 6-year plan running through 2031 to save more lives and boost patient experience.
2026-10292, Medicaid Program; Medicaid Managed Care State Directed Payments and Medicaid Fee-for-Service Targeted Medicaid Practitioner Payments
This proposed rule changes how states can pay Medicaid managed care plans and certain doctors to make sure payments are fair, efficient, and encourage enough providers to offer quality care. It affects states, Medicaid managed care organizations, and targeted Medicaid practitioners, aiming to keep payments balanced and services available. Comments on these changes are open until July 21, 2026, so stakeholders have time to weigh in before it’s finalized.
2026-10050, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program
Starting in 2027, health insurance plans on federal and state marketplaces will see new rules to make coverage fairer and easier to use. These changes affect insurance companies, agents, and people buying plans, including new fees, penalties, and better protections for those with hardships. Expect updates on plan quality, dental coverage limits, and longer-term catastrophic plans, all aiming to keep your health coverage solid and affordable.
2026-07205, Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges
This new rule will help Medicare, Medicaid, CHIP, and health plan companies share patient info more easily and speed up drug approval requests. It affects Medicare Advantage, Medicaid, CHIP, and health plans on federal exchanges, aiming to make care smoother and faster. These changes will start soon and could save time and money by cutting red tape.
Previous / Next Documents
Previous: 2025-08606, List of Correspondence From January 1, 2024, Through December 31, 2024
The U.S. Department of Education’s Office of Special Education Programs shared all their official letters from 2024 that explain how they interpret special education laws. These letters help schools, parents, and educators understand the rules better and make sure kids with disabilities get the support they deserve. Check them out anytime online to stay in the know—no surprises, just clear guidance!
Next: 2025-08608, Southern Nuclear Operating Company, Inc.; Vogtle Electric Generating Plant, Unit 4; License Amendment Application
Southern Nuclear wants a one-time 72-hour extension to fix a valve leak in the emergency air system at Vogtle Plant Unit 4. This change helps keep the plant safe without rushing repairs and affects how quickly they must act during certain emergencies. No extra costs or delays to the plant’s schedule are expected, just a smart safety tweak.